Pfizer Stock Prediction and Forecast [PFE]

AI-generated source summary

The analysis assesses Pfizer's stock as a hold/accumulate with a score of 0.801. It indicates a horizontal trend with minor fluctuations, projecting a 0.85% change over the next three months, and a potential range between -3.06% and 12.28%. Over 12 months, a -6.9% change is expected, varying from -22.77% to 2.76%. The last trading day showed a 1.48% gain, closing at $24.65, with 2.36% daily fluctuation, but warns of divergence due to falling volume during price gains. Fibonacci analysis is mentioned, the analyst ratings for the PFE rate the stock to buy. The insider power ratio is 97.518. Support is defined at $24.29, while the stock also has potential key levels to watch. A stop loss is recommended at $23.36 (-5.23%).

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   01 Nov 2025, 03:51 UTC

   The analyst published the original source item.

2. First prediction resolved

   04 Nov 2025, 14:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   04 Nov 2025, 14:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:13 UTC

   Tahlil Plus began monitoring the extracted predictions.